These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1992043)

  • 21. The therapeutic use of I-131 meta-iodobenzylguanidine (mIBG) in neuroblastoma: a phase II study in 12 patients.
    Hartmann O; Lumbroso JD; Lemerle M; Schlumberger M; Ricard M; Aubert B; Coornaert S; Merlin L; Parmentier C
    Prog Clin Biol Res; 1988; 271():655-67. PubMed ID: 3043455
    [No Abstract]   [Full Text] [Related]  

  • 22. Iodine-125-MIBG to treat neuroblastoma: preliminary report.
    Sisson JC; Hutchinson RJ; Shapiro B; Zasadny KR; Normolle D; Wieland DM; Wahl RL; Singer DA; Mallette SA; Mudgett EE
    J Nucl Med; 1990 Sep; 31(9):1479-85. PubMed ID: 2395016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [131I]MIBG as a first line treatment in advanced neuroblastoma.
    Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].
    Klingebiel T; Reuland P; Feine U; Niethammer D
    Nuklearmedizin; 1992 Dec; 31(6):209-12. PubMed ID: 1491958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans.
    Hattner RS; Pounds TR; Matthay KK
    Clin Nucl Med; 1994 Nov; 19(11):985-8. PubMed ID: 7842595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of recurrent stage IV neuroblastomas with 131I-MIBG and HBO Six years follow-up.
    van der Kleij AJ; Voûte PA
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():28-9. PubMed ID: 8946044
    [No Abstract]   [Full Text] [Related]  

  • 28. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.
    Mastrangelo R; Lasorella A; Troncone L; Rufini V; Iavarone A; Riccardi R
    J Nucl Biol Med (1991); 1991; 35(4):252-4. PubMed ID: 1823829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical remission and reduction of malignant pheochromocytoma treated with iodine-131-meta-iodobenzylguanidine].
    Piñero A; Hernández A; Rodríguez JM; Parrilla P
    Med Clin (Barc); 1996 Nov; 107(19):755-6. PubMed ID: 9082096
    [No Abstract]   [Full Text] [Related]  

  • 30. New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.
    Mairs RJ; Zalutsky MR
    Br J Cancer; 1995 Jul; 72(1):250. PubMed ID: 7599061
    [No Abstract]   [Full Text] [Related]  

  • 31. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
    Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
    Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International Society of Pediatric Oncology, Italian Society of Radiology and Nuclear Medicine, Italian Society of Biology and Nuclear Medicine, and Associazione Genitori Oncologia Pediatrica. IVth International Workshop in Pediatric Oncology: "The role of MIBG in therapy, diagnosis, and monitoring of neuroblastoma". Rome, Italy, September 22 and 23, 1986. Proceedings.
    Med Pediatr Oncol; 1987; 15(4):157-228. PubMed ID: 3657702
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma].
    Guerra P
    Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in children.
    Bolster AA; Hilditch TE
    Br J Radiol; 1995 Nov; 68(815):1263. PubMed ID: 8542240
    [No Abstract]   [Full Text] [Related]  

  • 35. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
    De Kraker J; Hoefnagel CA; Caron H; Valdés Olmos RA; Zsiros J; Heij HA; Voûte PA
    Eur J Cancer; 1995; 31A(4):600-2. PubMed ID: 7576977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
    Weber W; Weber J; Senekowitsch-Schmidtke R
    Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis, monitoring and therapy of neuroblastoma using I-131 meta-iodobenzylguanidine].
    Melino G; Taucci M; De Nardo D; Clerico A; Mango L; Antolini M; Caputo V; Castello MA
    Minerva Pediatr; 1986 Dec; 38(23-24):1083-93. PubMed ID: 3561358
    [No Abstract]   [Full Text] [Related]  

  • 38. The treatment of resistant neuroblastoma with 131I-mIBG: alternative methods of dose prescription.
    Fielding SL; Flower MA; Ackery DM; Kemshead J; Lashford LS; Lewis IJ
    Radiother Oncol; 1992 Sep; 25(1):73-6. PubMed ID: 1410594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
    Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
    J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of metastatic para-aortic paraganglioma by surgery, radiotherapy and I-131 mIBG.
    Ball AB; Tait DM; Fisher C; Sinnett HD; Harmer CL
    Eur J Surg Oncol; 1991 Oct; 17(5):543-6. PubMed ID: 1936304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.